Company chart and information is provided by TradingView based on 15-minute-delayed data.
ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors.
| Website: | www.chromadex.com |
| Email: | InvestorRelations@chromadex.com |
| Main Phone: | +1 310 388-6706 |
| Address: | 10900 Wilshire Boulevard |
| Address 2: | Suite 650 |
| State: | CA |
| City / Town: | Los Angeles |
| Country: | US |
| Postal Code: | 90024 |
| Exchange: | NSC |
| CEO: | Robert N. Fried |
| Employees: | 110 |
| NAICS: | Medicinal and Botanical Manufacturing(325411) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
